David Spiegel

Dr. David Spiegel is Willson Professor and Associate Chair of Psychiatry & Behavioral Sciences, Director of the Center on Stress and Health, and Medical Director of the Center for Integrative Medicine at Stanford University School of Medicine, where he has been a member of the academic faculty since 1975, and was Chair of the Stanford University Faculty Senate from 2010-2011.

Dr. Spiegel has more than 50 years of clinical and research experience studying psycho-oncology, stress and health, pain control, psychoneuroendocrinology, sleep, hypnosis, and conducting randomized clinical trials involving psychotherapy for cancer patients. He has published thirteen books, 435 scientific journal articles, and 175 book chapters on hypnosis, psychosocial oncology, stress physiology, trauma, and psychotherapy.

His research has been supported by the National Institute of Mental Health, the National Cancer Institute, the National Institute on Aging, the National Center for Complementary and Integrative Health, the John D. and Catherine T. MacArthur Foundation, the Fetzer Institute, the Dana Foundation for Brain Sciences, and the Nathan S. Cummings Foundation.

Dr. Spiegel was a member of the work groups on stressor and trauma-related disorders for the DSM-IV and DSM-5 editions of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders. He is Past President of the American College of Psychiatrists and the Society for Clinical and Experimental Hypnosis and is a Member of the National Academy of Medicine. He was invited to speak on hypnosis at the World Economic Forum in Davos in 2018.

Dr. Spiegel is co-founder and scientific advisor to Reveri Health, Inc.    The Reveri app, available at the App Store, Google Play, and www.reveri.com, provides AI enhanced individualized instructions for hypnosis experiences designed to help manage stress, control pain, get to sleep, enhance focus, manage fear of flying, stop smoking, eat better, and improve athletic performance.  Studies of large numbers of Reveri users show immediate reduction in stress, pain, and smoking cessation.  The App has had more than 1.4 million downloads in 109 countries.